| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 10/02/1997 | WO1997035602A1 Use of vasopressin receptor antagonist for regulation of acth release |
| 10/02/1997 | WO1997035581A1 Interleukin-6 production inhibitor |
| 10/02/1997 | WO1997035571A1 Benzothiophenes, formulations containing same, and methods |
| 10/02/1997 | WO1997035538A2 Tumor necrosis factor alpha convertase |
| 10/02/1997 | CA2250570A1 Formulations of ob protein |
| 10/02/1997 | CA2249985A1 Tumour necrosis factor alpha convertase |
| 10/02/1997 | CA2249454A1 Diabetes treatment |
| 10/01/1997 | EP0798002A1 Inhibition of vascular stenosis |
| 10/01/1997 | EP0798001A2 Collagen containing preparations for strengthening bone |
| 10/01/1997 | EP0797999A2 Formulations of obesity protein |
| 10/01/1997 | EP0797592A1 Human stanniocalcin-alpha |
| 10/01/1997 | EP0797454A1 Improved adenoviral vectors and producer cells |
| 10/01/1997 | EP0797443A1 A pharmaceutical composition with improved bio-availability of inositol phosphate |
| 10/01/1997 | EP0596015B1 Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for the preparation thereof |
| 10/01/1997 | CN1161035A Hypolipidemic 1,4-benzothiazepine-1,1-dioxides |
| 10/01/1997 | CN1160998A Method of inhibiting conditions associated with neuropeptide Y |
| 09/30/1997 | US5672705 Antiischemic agents treating nervous system disorders, huntington' disease, alzheimer's disease, parkinson's disease |
| 09/30/1997 | US5672618 Protein kinase C inhibitors |
| 09/30/1997 | US5672596 Animal growth controllers |
| 09/30/1997 | US5672356 Bioadhesive pharmaceutical composition for the controlled release of active principles |
| 09/30/1997 | US5671848 Tagged antibodies capable of recognizing the non-variable region of the anti-heat shock protein 65 antibody to be detected |
| 09/29/1997 | CA2200267A1 Novel sphingolipids and a process thereto |
| 09/25/1997 | WO1997034590A1 New use of ammonium compounds and/or urea |
| 09/25/1997 | WO1997017446A3 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 09/25/1997 | CA2249704A1 New use of ammonium compounds and/or urea |
| 09/24/1997 | EP0796864A2 Steroidal glycosides for treating hypercholesterolemia |
| 09/24/1997 | EP0796863A2 Steroidal glycosides for treating hypercholesterolemia |
| 09/24/1997 | EP0796862A2 Steriodal glycosides for treating hypercholesterolemia |
| 09/24/1997 | EP0796855A1 Inhibitors of bone resorption and vitronectin receptor antagonists |
| 09/24/1997 | EP0796846A1 2-Aryl substituted pyridines |
| 09/24/1997 | EP0796623A2 Pharmaceutical preparation for the treatment of blood coagulation disorders |
| 09/24/1997 | EP0796325A1 Human vascular ibp-like growth factor |
| 09/24/1997 | EP0796270A2 Peptide compounds for prevention and/or treatment of no-mediated diseases |
| 09/24/1997 | EP0796238A1 Method of stabilizing polyunsaturated fatty acids and their application in therapy and cosmetics |
| 09/24/1997 | EP0796106A1 Protracted glp-1 compositions |
| 09/24/1997 | CN1160402A Purine and guanine compounds as inhibitors of PNP |
| 09/24/1997 | CN1160353A Hydration compositions for human or animal bodies |
| 09/24/1997 | CN1160347A Use of indole drivs. for treatment of dermatological disorders peripheral neuropathied, arthritis, headache, orofacial pain, allergic or chronic obstructive airways desease, glaucoma and ocular. |
| 09/24/1997 | CN1160045A Matrix metalloprotease inhibitors |
| 09/24/1997 | CN1160042A Ortho-substd. benzoyl guanidines, their preparing process and use as medicine and diagnostic reagent, and medicine contg. same |
| 09/24/1997 | CN1159950A Bioadhesive pharmaceutical composition for controlled release of active principles |
| 09/24/1997 | CN1035925C Method for preparation of cytotropic non-homogeneous molecular lipid |
| 09/23/1997 | US5670547 Moisturizing vehicle for topical application of vitamin A acid |
| 09/23/1997 | US5670535 Thiophene compounds |
| 09/23/1997 | US5670527 Cytokine inhibitors useful in treating asthma, osteoporosis, arthritis, inflammation, sepsis, cardiovascular disorders, diabetes, multiple sclerosis, skin disorders |
| 09/23/1997 | US5670338 Genetic engineering; therapy for osteoporosis |
| 09/23/1997 | US5670150 Non-depleting CD4-specific monoclonal antibodies for the treatment of insulin-dependent diabetes mellitus (IDDM) |
| 09/20/1997 | CA2200394A1 A pharmaceutical preparation for treating blood coagulation disorders |
| 09/20/1997 | CA2200175A1 2-aryl-substituted pyridines |
| 09/20/1997 | CA2199923A1 Novel inhibitors of bone reabsorption and antagonists of vitronectin receptors |
| 09/18/1997 | WO1997033902A1 Human tumor necrosis factor delta and epsilon |
| 09/18/1997 | WO1997033887A1 Spirocycle integrin inhibitors |
| 09/18/1997 | WO1997033883A1 Novel pyrimidine compounds useful in treating cytokine mediated diseases |
| 09/18/1997 | WO1997033882A1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 09/18/1997 | WO1997033881A1 Bicyclic-aromatic compounds |
| 09/18/1997 | WO1997033856A1 Diaromatic propynyl or dienyl compounds |
| 09/18/1997 | WO1997033614A1 Use of coxiella bacteria to treat autoimmune disease |
| 09/18/1997 | WO1997025351A3 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR |
| 09/18/1997 | WO1997020569A3 Bioartificial devices and cellular matrices therefor |
| 09/18/1997 | CA2249733A1 Spirocycle integrin inhibitors |
| 09/18/1997 | CA2248586A1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 09/17/1997 | EP0795553A1 Production of isoflavone enriched fractions from soy protein extracts |
| 09/17/1997 | EP0795011A1 Method and compositions for reducing cholesterol absorption |
| 09/17/1997 | EP0683773B1 Hypolipidaemic condensed 1,4-thiazepines |
| 09/17/1997 | EP0525123B1 Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones |
| 09/17/1997 | CN1159805A Nvel imidazole derivatives, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
| 09/17/1997 | CN1159797A Aryloxy and arylthiopropanolamine derivative suseful as beta 3-adrenoreceptor agonists and antagonists of the beta 1 and beta 2-adrenoreceptors and pharmaceutical composition thereof |
| 09/17/1997 | CN1159758A Peptide, a method of obtaining it and a pharmaceutical compound based on it |
| 09/17/1997 | CN1159444A Sulfuryl amino substituted benzoyl guanidine, preparation process and applications as medicine or diagnostic agent and the medicine containing same |
| 09/16/1997 | US5668180 Alkoxyaryl compounds |
| 09/16/1997 | US5668161 Substituted thiazoles for the treatment of inflammation |
| 09/16/1997 | US5668158 Cyclic amino acid derivatives |
| 09/16/1997 | US5668155 Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders |
| 09/16/1997 | US5668152 Protein kinase C inhibitors |
| 09/16/1997 | US5668151 Useful as anorexigenic agents in promoting weight loss and treating eating disorders |
| 09/16/1997 | US5668143 Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action |
| 09/16/1997 | US5668139 Xanthine derivatives |
| 09/16/1997 | US5668137 N-heterocyclic sulfonamides having endothelin receptor activity |
| 09/16/1997 | US5668136 Trisubstituted benzene derivatives, composition and methods of treatment |
| 09/16/1997 | US5668126 Bile acid derivatives, processes for their preparation, and use as pharmaceuticals |
| 09/16/1997 | US5667775 Phosphate-binding polymers for oral administration |
| 09/16/1997 | CA2000830C 0-(3-amino-2-hydroxypropyl)-hydroximic acid halides and process for preparing the same |
| 09/12/1997 | WO1997032883A1 Azolobenzazepine derivatives as neurologically active agents |
| 09/12/1997 | WO1997032575A1 Mercapto derivatives as inhibitors of cyclooxygenases |
| 09/12/1997 | WO1997032574A1 Serum cholesterol lowering agent |
| 09/12/1997 | CA2247453A1 Azolobenzazepine derivatives as neurologically active agents |
| 09/12/1997 | CA2199351A1 Benzothiophenes, formulations containing same, and methods |
| 09/11/1997 | CA2199414A1 Stable carotenoid emulsions suitable for parenteral administration |
| 09/10/1997 | EP0794175A2 Process for producing vitamin D3 derivatives |
| 09/10/1997 | EP0794172A1 Orthosubstituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them |
| 09/10/1997 | EP0793660A1 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
| 09/10/1997 | EP0793649A1 18,19-dinor-vitamin d compounds |
| 09/10/1997 | EP0793648A1 18-nor-vitamin d compounds |
| 09/10/1997 | EP0793646A1 Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus |
| 09/10/1997 | EP0793643A1 Matrix metalloprotease inhibitors |
| 09/10/1997 | EP0619304B1 22-oxacholecalciferol derivative and production thereof |
| 09/10/1997 | CN1158855A Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmacueticals |
| 09/10/1997 | CN1158850A New thiophene compounds, process for their preparation and pharmaceutical compositions containing them |
| 09/10/1997 | CN1158844A Tertiary amines |
| 09/10/1997 | CN1035801C Microgranular preparation useful in delivery of biologically active materials to intestinal regious of animals |